Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer
ClinicalTrials.gov study NCT00334802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer
ClinicalTrials.gov study NCT00336700. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00114244. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT01916109. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02506959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
ClinicalTrials.gov study NCT00820898. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
ClinicalTrials.gov study NCT04039867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov study NCT00244933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors
ClinicalTrials.gov study NCT04616534. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advance
ClinicalTrials.gov study NCT03941093. IPD Sharing: UNDECIDED. Countries: 12. Publications: 0.
Nivolumab, Cisplatin, and Pemetrexed Disodium or Gemcitabine Hydrochloride in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery
ClinicalTrials.gov study NCT03366766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT02241551. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH
ClinicalTrials.gov study NCT04251065. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants W
ClinicalTrials.gov study NCT04182204. IPD Sharing: YES. Countries: 16. Publications: 0.
Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00378573. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
ClinicalTrials.gov study NCT02300610. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers
ClinicalTrials.gov study NCT00832637. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
ClinicalTrials.gov study NCT00388154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT00192036. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)
ClinicalTrials.gov study NCT01270724. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.